Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Glioblastoma
×
rindopepimut
×
Clear all
Filters
3
NCT01498328
2020-02-17
ReACT
Celldex Therapeutics
Phase 2
Completed
127 enrolled
NCT01480479
2018-01-16
ACT IV
Celldex Therapeutics
Phase 3
Completed
745 enrolled
NCT03068650
2017-10-18
CDX-110
Celldex Therapeutics
No longer available